Found 305 matching trials
Study of Dupilumab Monotherapy Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis PHASE3 This is a randomized, double-blind, placebo-controlled, parallel group stud...
Show More Location
Multiple Locations
Learn More & Join Trial
Real Life Study of Biologicals in Patients With Severe CRSwNP N/A This study is a pragmatic, real-life, observational study recruiting adult ...
Show More Location
Ghent University Hospital
Learn More & Join Trial
Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP PHASE4 Hypothesis: The investigators hypothesize that in patients with CRSwNP who ...
Show More Location
University of Virginia Health System
Learn More & Join Trial
A Study to Evaluate the Biosimilarity of GLR1044 Injection and Dupilumab Injection (Dupixent®) in Healthy Adult Male Subjects PHASE1 This is a randomized, double-blind, single-dose, parallel comparison biosim...
Show More Location
Beijing Gobroad Hospital
Learn More & Join Trial
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment N/A Study on ophthalmological comorbidities and the underlying pathomechanisms ...
Show More Location
University Medical Center Utrecht
Learn More & Join Trial
Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD) PHASE3 The primary objective of the study is to assess the long-term safety of dup...
Show More Status
Active Not Recruiting
Location
Regeneron Investigational Site
Learn More & Join Trial
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) N/A The goal of this observational study is to learn more about the real-world ...
Show More Location
Onze Lieve Vrouw hospital Aalst
Learn More & Join Trial
The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment PHASE4 The utility of functionally relevant signature genes in assessing the clini...
Show More Location
Bernstein Clinical Research Center
Learn More & Join Trial
Dupilumab Compassionate Use Study N/A This is a single patient expanded access, compassionate and non-emergency u...
Show More Status
Approved For Marketing
Location
Multiple Locations
Learn More & Join Trial
Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) PHASE3 Primary Objective:
This study aimed to demonstrate the efficacy of dupilum...
Show More Location
California Allergy and Asthma Medical Group, Inc. Site Number : 8400019
Learn More & Join Trial